Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cancer
    • MRI may predict...

    MRI may predict prognosis of surgery in rectal cancer: JAMA

    Written by Medha Baranwal Baranwal Published On 2019-04-23T19:25:27+05:30  |  Updated On 23 April 2019 7:25 PM IST
    MRI may predict prognosis of surgery in rectal cancer: JAMA
    Magnetic resonance imaging,MRI may predict prognosis of surgery in rectal cancer, finds new study.

    Magnetic resonance imaging (MRI) is an imaging modality that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body.An MRI scanner is a large tube that contains powerful magnets. The patient is made to lie inside the tube during the scan.


    The results of an MRI scan can be used to help diagnose conditions, plan treatments and assess how effective previous treatment has been.


    The use of magnetic resonance imaging (MRI) criteria to select patients with good prognosis rectal cancer for primary surgery results in a low rate of positive circumferential resection margin (CRM), according to a recent study.


    Results of the study, published in the journal JAMA Oncology suggests that chemoradiotherapy (CRT) may not be necessary for all patients with stage II and III rectal cancer.


    Chemoradiotherapy (CRT), followed by surgery, is the recommended approach for stage II and III rectal cancer. While CRT decreases the risk of local recurrence, it does not improve survival and leads to poorer functional outcomes than surgery alone. Therefore, new approaches to better select patients for CRT are important. Erin D. Kennedy, Department of Surgery, University of Toronto, Toronto, Ontario, Canada, and colleagues conducted conduct a phase 2 study to evaluate the safety and feasibility of using MRI criteria to select patients with “good prognosis” rectal tumors for primary surgery.


    The study included 82 patients newly diagnosed with rectal cancer with an MRI-predicted good prognosis between September 2014 and October 2016 at 12 high-volume colorectal surgery centers in Canada. MRI criteria for good-prognosis tumors consisted of: distance to the mesorectal fascia > 1 mm; definite T2, T2/early T3, or definite T3 with < 5 mm of the extramural depth of invasion; and absent or equivocal extramural venous invasion.


    The primary outcome measure was a positive circumferential resection margin rate. Most patients were male (74%), and the median age at surgery was 66 years.


    Also Read: High dose Vitamin D delays progression of colorectal cancer, finds JAMA trial

    Key findings of the study:

    • Based on MRI, most tumors were midrectal (65% [n = 53]), T2/early T3 (60% [n = 49]), with no suspicious lymph nodes (63% [n = 52]).

    • On final pathology, 91% (n = 75) of tumors were T2 or greater, 29% (n = 24) were node positive, and 59% (n = 48) were stage II or III.

    • The positive CRM rate was 4 of 82 (4.9%; 95% CI, 0.2%-9.6%).

    • Overall, 25 patients (30%) received adjuvant treatment, with 6 receiving chemoradiotherapy and 19 receiving chemotherapy. Among the 48 patients with stage II or III tumors, 42 (88%) did not receive any form of radiotherapy.


    Also Read: New stool test- at home screening option for colorectal cancer

    "The use of MRI criteria to select patients with good prognosis rectal cancer for primary surgery results in a low rate of positive CRM and suggests that CRT may not be necessary for all patients with stage II and III rectal cancer," concluded the authors.

    Chemoradiotherapycircumferential resection marginColorectal CancerErin D. KennedyJAMA Oncologymagnetic resonance imagingMRIprognosisradiotherapyrectal cancerrectal tumorsstage II rectal cancerstage III rectal cancertumors
    Source : With inputs from JAMA Oncology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok